BioNxt Solutions Provides Update To Annual General Meeting Matters Due To Canadian Postal Strike And IR Activities
BioNxt (OTCQB:BNXTF) advised shareholders that its 2025 annual general meeting will be held in person on November 7, 2025 at 10:00 a.m. (Vancouver). Due to the Canada Post strike, shareholders are directed to electronic copies of the Notice of Meeting, Information Circular and proxy via SEDAR+ and the company website, or to contact Investor Relations for copies.
The company outlined alternative proxy submission methods (fax, hand delivery, online via Computershare) and a 48-hour proxy deadline. BioNxt disclosed a service agreement with Native Ads for a digital marketing campaign with a retainer up to US$200,000 and term up to six months. The company confirmed compliance with NI 51-102 proxy filing rules and reliance on the CSA blanket order exemption.
BioNxt (OTCQB:BNXTF) ha informato agli azionisti che la sua assemblea generale annuale 2025 si svolgerà di persona il 7 novembre 2025 alle 10:00 (Vancouver). A causa dello sciopero di Canada Post, agli azionisti sono fornite copie elettroniche della Notifica della Riunione, della Circolare Informativa e della procura tramite SEDAR+ e sul sito dell’azienda, oppure contattare l’Ufficio Relazioni con gli Investitori per copie.
L’azienda ha definito metodi alternativi di invio della procura (fax, consegna a mano, online tramite Computershare) e una scadenza di 48 ore per la procura. BioNxt ha comunicato un accordo di servizio con Native Ads per una campagna di marketing digitale con un retainer fino a US$200.000 e una durata fino a sei mesi. L’azienda ha confermato la conformità alle norme NI 51-102 relative al deposito delle procure e l’affidamento all’esenzione dell’ordine quadro CSA.
BioNxt (OTCQB:BNXTF) informó a los accionistas que su reunión anual general 2025 se celebrará en persona el 7 de noviembre de 2025 a las 10:00 a.m. (Vancouver). Debido a la huelga de Canada Post, se indica a los accionistas copias electrónicas de la Notificación de la Reunión, la Circular de Información y la procuración vía SEDAR+ y el sitio web de la empresa, o contactar a Relaciones con Inversores para copias.
La empresa describió métodos alternativos de presentación de la procuración (fax, entrega en mano, en línea vía Computershare) y una fecha límite de 48 horas para la procuración. BioNxt comunicó un acuerdo de servicios con Native Ads para una campaña de marketing digital con un anticipo de hasta US$200,000 y un plazo de hasta seis meses. La empresa confirmó el cumplimiento con las normas NI 51-102 de presentación de procuraciones y la dependencia de la exención por orden marco de la CSA.
BioNxt (OTCQB:BNXTF)는 주주들에게 2025년 연례 일반 주총이 2025년 11월 7일 오전 10:00(밴쿠버 시간)에 대면으로 개최될 것이라고 알렸습니다. 캐나다 포스트 파업으로 주주들은 회의 공지, 정보 순환 및 위임장을 SEDAR+와 회사 웹사이트를 통해 전자 사본으로 받거나 투자자 관계부서에 연락해 사본을 받으시기 바랍니다.
회사는 대리권 제출의 대체 방법(팩스, 직접 전달, Computershare를 통한 온라인)을 설명하고 48시간의 대리권 마감 시간을 명시했습니다. BioNxt는 Native Ads와의 서비스 계약을 통해 디지털 마케팅 캠페인을 진행하며 선급금은 최대 미화 200,000달러, 기간은 최대 6개월입니다. 회사는 NI 51-102 대리권 제출 규정을 준수하고 CSA blanket order 면제를 활용한다는 점을 확인했습니다.
BioNxt (OTCQB:BNXTF) a informé ses actionnaires que son assemblée générale annuelle 2025 se tiendra en personne le 7 novembre 2025 à 10 h 00 (Vancouver). En raison de la grève de la poste canadienne, les actionnaires sont invités à prendre connaissance des copies électroniques de l’Avis de réunion, de la Circulaire d’information et de la procuration via SEDAR+ et le site de la société, ou à contacter les Relations investisseurs pour obtenir des copies.
La société a décrit des méthodes alternatives de soumission de la procuration (fax, remise en main propre, en ligne via Computershare) et une échéance de procuration de 48 heures. BioNxt a dévoilé un contrat de service avec Native Ads pour une campagne de marketing numérique avec un acompte jusqu’à US$200 000 et une durée allant jusqu’à six mois. La société a confirmé sa conformité aux règles NI 51-102 sur le dépôt des procurations et le recours à l’exemption par ordonnance-cadre de la CSA.
BioNxt (OTCQB:BNXTF) informierte die Aktionäre, dass seine Jahreshauptversammlung 2025 am 7. November 2025 um 10:00 Uhr (Vancouver) persönlich stattfinden wird. Aufgrund des Streiks der Canada Post wird den Aktionären empfohlen, elektronische Kopien der Mitteilung über die Versammlung, der Informationsrunde und der Vollmacht über SEDAR+ und die Website des Unternehmens zu beziehen oder sich für Kopien an Investor Relations zu wenden.
Das Unternehmen erläuterte alternative Methoden zur Einreichung der Vollmacht (Fax, persönliche Übergabe, Online über Computershare) und eine 48-Stunden-Frist für die Vollmacht. BioNxt kündigte eine Dienstleistungsvereinbarung mit Native Ads für eine digitale Marketingkampagne an, mit einer Retainer-Höhe bis zu US$200.000 und einer Laufzeit von bis zu sechs Monaten. Das Unternehmen bestätigte die Einhaltung der NI 51-102-Regeln zur Einreichung von Vollmachten und die Nutzung der CSA- Blanket Order-Ausnahme.
BioNxt (OTCQB:BNXTF) أبلغت المساهمين بأن اجتماعها السنوي لعام 2025 سيعقد حضورياً في 7 نوفمبر 2025 الساعة 10:00 صباحاً (فانكوفر). وبسبب إضراب البريد الكندي، يتم توجيه المساهمين إلى نسخ إلكترونية من إشعار الاجتماع، و< b>دائرة المعلومات و< b>الوكالة عبر SEDAR+ وموقع الشركة للحصول على النسخ، أو التواصل مع قسم علاقات المستثمرين للحصول على نسخ.
حددت الشركة طرق تقديم الوكالة البديلة (فاكس، التسليم باليد، عبر الإنترنت عبر Computershare) وفترة انتهاء صلاحية الوكالة خلال 48 ساعة. كما أعلنت BioNxt عن اتفاقية خدمات مع Native Ads لحملة تسويقية رقمية بمبلغ حتى US$200,000 وبمدة تصل إلى ستة أشهر. أكدت الشركة الامتثال لقواعد NI 51-102 بشأن تقديم الوكالات والاعتماد على استثناء CSA blanket order.
BioNxt (OTCQB:BNXTF) 通知股东，其< b>2025 年年度股东大会将于 2025 年 11 月 7 日上午 10:00（温哥华时间）举行。由于加拿大邮政罢工，股东被指引通过 SEDAR+ 与公司网站获取会议通知、信息通函和委托书的电子副本，或联系投资者关系以获取副本。
公司还描述了替代提交代理的方法（传真、现场递交、通过 Computershare 在线）以及 48 小时的代理截止时间。BioNxt 公布与 Native Ads 的 服务协议，用于数字营销活动，托管费最高为 US$200,000，期限最长六个月。公司确认遵守 NI 51-102 的代理提交规则，并依赖 CSA Blanket Order 的豁免。
- Service agreement: retainer up to US$200,000 for digital marketing
- Marketing term: campaign up to six months or until retainer depleted
- Electronic meeting materials available on SEDAR+ and company website
- Company confirmed compliance with NI 51-102 proxy filing requirements
- Canada Post strike may delay physical delivery of proxy materials
- All proxies must be received 48 hours before the meeting deadline
VANCOUVER, BC, BC / ACCESS Newswire / October 9, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) wishes to advise its shareholders, due to the Canada Post mail strike, of alternative ways to vote their shares for the upcoming annual general meeting of shareholders of the Company (the "Meeting").
The Meeting will be held in person at the offices of McMillan LLP, 1500 Royal Centre, 1055 West Georgia Street, Vancouver, British Columbia, Canada at 10:00 a.m. (local time) on November 7, 2025. The Meeting is being held for the following purposes:
To receive and consider the audited consolidated financial statements of the Company for the financial year ended December 31, 2024, together with the auditor's report thereon and the related management discussion and analysis.
To elect directors of the Company for the ensuing year.
To appoint Davidson & Company LLP, Chartered Professional accountants, as auditor of the Company for the ensuing year and to authorize the directors to fix the auditor's remuneration.
To consider any permitted amendment to or variation of any matter identified in this Notice and to transact such other business as may properly come before the Meeting or at any adjournment or postponement thereof.
Electronic copies of the Notice of Meeting and Information Circular and the form of proxy prepared in respect of the Meeting have been mailed to shareholders and are available under the Company's SEDAR+ profile at www.sedarplus.ca and on the Company's website at www.bionxt.com. Shareholders who do not receive these Meeting materials on a timely basis through the normal course of delivery are encouraged to access them via SEDAR+ or to contact Hugh Rogers at 778-598-2698 or investor.relations@bionxt.com to obtain copies.
Shareholders are not required to be present at the Meeting and can vote their shareholdings in advance of the Meeting. All proxies must be received by Computershare Investor Services Inc. ("Computershare") at least 48 hours (excluding Saturdays, Sundays and holidays) before the Meeting, and may be submitted to Computershare via fax within North America at 1-866-249-7775, outside North America at (416) 263-9524, or by hand to 320 Bay Street, 14th Floor, Toronto, ON M5H 4A6. Registered shareholders may call Computershare at 1-800-564-6253 to obtain a control number to vote online (go to www.investorvote.com and enter the control number). Please note that the form of proxy found on SEDAR+ is not personalized and each registered shareholder must ensure its name and address are added, and that the proxy is duly signed and dated, before submission.
Beneficial holders should contact their brokerage house or depositary company directly, as each intermediary has its own form of proxy return instructions.
Any questions with respect to voting matters may be directed to Computershare, the Company's transfer agent, at 1-800-564-6253.
The Company has complied with the filing requirements for proxy-related material in Section 9.3 of National Instrument 51-102 Continuous Disclosure Requirements, and has satisfied all the conditions to rely, and is relying, on the exemption from the requirement to send proxy related materials pursuant to the CSA Coordinated Blanket Order 51-931.
The Company has entered into a service agreement with Native Ads, Inc. ("Native Ads") (244 Fifth Avenue, Suite N-249 New York, N.Y. 10001 USA, 1-866-773-3540, info@nativeads.com) pursuant to which Native Ads will provide a marketing campaign for a total retainer of up to US
About BioNxt Solutions Inc.
BioNxt Solutions Inc. is a bioscience innovator focused on next‐generation drug delivery technologies, diagnostic screening systems, and active pharmaceutical ingredient development. The Company's proprietary platforms-Sublingual (Thin‐Film), Transdermal (Skin Patch), and Oral (Enteric‐Coated Tablets)-target key therapeutic areas, including autoimmune diseases, neurological disorders, and longevity. With research and development operations in North America and Europe, BioNxt is advancing regulatory approvals and commercialization efforts, primarily focused on European markets. BioNxt is committed to improving healthcare by delivering precise, patient‐centric solutions that enhance treatment outcomes worldwide.
BioNxt is listed on the Canadian Securities Exchange: BNXT, OTCQB Markets: BNXTF and trades in Germany under WKN: A3D1K3. To learn more about BioNxt, please visit www.bionxt.com.
Investor Relations & Media Contact
Hugh Rogers, Co‐Founder, CEO and Director
Email: investor.relations@bionxt.com
Phone: +1 778.598.2698
Web: www.bionxt.com
LinkedIn: https://www.linkedin.com/company/bionxt‐solutions
Instagram: https://www.instagram.com/bionxt
THIS NEWS RELEASE DOES NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF ANY OFFER TO BUY, NOR SHALL THERE BE ANY SALE OF THESE SECURITIES IN ANY JURISDICTION IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL. THE DEBENTURES AND THE SHARES WHICH MAY BE ISSUED ON EXERCISE THEREOF HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "U.S. SECURITIES ACT") AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES ABSENT REGISTRATION OR AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE U.S. SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS.
Neither the CSE nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
SOURCE: BioNxt Solutions Inc.
View the original press release on ACCESS Newswire
FAQ
When and where is BioNxt's annual general meeting on November 7, 2025?
How can BNXTF shareholders vote given the Canada Post strike?
What is the proxy submission deadline for BioNxt's November 7, 2025 meeting?
What marketing agreement did BioNxt disclose and how large is it?
Where can BNXTF shareholders access the Notice of Meeting and Information Circular?
Who should beneficial shareholders contact to return proxy instructions for BNXTF?
Did BioNxt meet Canadian proxy filing rules for the November 2025 meeting?
